Common Shares Outstanding: The number of class A shares currently held by investors.
AC Immune (ACIU) Common Shares Outstanding data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.10M |
|
$-21.17M |
|
-- |
|
$1.10M |
|
$22.65M |
|
$-21.55M |
|
$0.38M |
|
$-21.17M |
|
$-21.17M |
|
$-21.17M |
|
$-21.17M |
|
$-21.17M |
|
$-21.17M |
|
$-21.55M |
|
$-20.87M |
|
100.41M |
|
100.41M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$169.23M |
|
$3.07M |
|
$65.57M |
|
$234.81M |
|
$110.40M |
|
-- |
|
$18.95M |
|
$129.35M |
|
$105.45M |
|
$49.37M |
|
$105.45M |
|
|
Common Shares Outstanding |
-- |
| Cash Flow Statement Financials | |
$-20.93M |
|
$3.37M |
|
$-0.29M |
|
$40.35M |
|
$22.20M |
|
$-18.15M |
|
$1.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1956.57% |
|
-1956.57% |
|
-- |
|
-1922.12% |
|
-1922.12% |
|
$-21.33M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.50 |
|
180.73 |
|
-20.07% |
|
-42.88% |
|
-9.02% |
|
-20.07% |
|
-- |
|
$-0.21 |
|
$-0.21 |
|